Skip to main content

Table 2 Concurrent therapies taken by patient cohort at the initiation of AZLI as part of their routine care

From: The effects of inhaled aztreonam on the cystic fibrosis lung microbiome

Medication

Responders (n = 14)

Non-responders (n = 10)

Nutritional

 CF specific multi-vitamin

14

10

 Vitamin D

14

10

 Pancreatic enzymes

12

10

Chronic oral antibiotic therapies

 Azithromycin

11

9

 Ciprofloxacin

2

2

 Other antibioticsa

0

3

Inhaled antibacterial cycling

 AZLI sole inhaled antibiotic

12

5

 Tobramycin supplemented (TIS/TIP)

1

4

 Colistin supplemented (colomycin)

1

1

Respiratory

 Short-acting beta-agonist

11

9

 Long-acting beta-agonist

14

9

 Inhaled corticosteroid

8

2

 Nasal steroid

5

1

 Dornase alpha (DNase)

10

8

 Hypertonic saline

8

6

Gastrointestinal

 PPI (pantoprazole/omeprazole)

4

6

 Ursodiol

2

1

 Ultratums

12

10

 Laxative

3

4

Endocrine

 Oral birth control pill

2

1

 Insulin

4

4

 Oral hypoglycemic

1

2

Other

 Antidepressant

5

3

 NSAID

0

1

  1. aOther antibiotics include amoxicillin, cefotaxime, and septra